先駆け審査指定制度対象品目の募集 against 大日本住友製薬 株式会社
大日本住友製薬 株式会社 (薬事法)
薬事法Ministry of Health, Labour and WelfareOctober 5, 2017
Action summary
- Company
- 大日本住友製薬 株式会社Japanese onlyOriginal: 大日本住友製薬 株式会社
- Governing law
- 薬事法薬事法
- Action type
- 先駆け審査指定制度対象品目の募集先駆け審査指定制度対象品目の募集
- Action date
- October 5, 2017
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
Violation
Machine-translated summary — verify against original
Unapproved Parkinson's disease treatment using non-self iPS cell-derived dopamine neural precursor cells
Show original Japanese text
非自己iPS細胞由来ドパミン神経前駆細胞 パーキンソン病
Source
Original Ministry of Health, Labour and Welfare announcement (in Japanese)The original Japanese disclosure is the authoritative record.
Watch this company
Get an email when 大日本住友製薬 株式会社 has new enforcement actions or registry changes (representative, address, business status). Sign-in is via a one-time email link — no password.
Language
日本語版を見る (Japanese)About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.